Focus: LeMaitre Vascular is a medical device company specializing in vascular surgical devices for cardiovascular applications, headquartered in Australia. The company has a diversified portfolio spanning embolectomy catheters, vascular grafts, and surgical patches.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow LeMaitre Vascular to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Core thromboembolism intervention device; clinical maturity indicated by 1 active trial.
Help build intelligence for LeMaitre Vascular
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from LeMaitre Vascular's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Only Phase 2 program in portfolio; dialysis access is stable, recurring revenue segment.
Branded product targeting high-acuity aneurysm repair; suggests established market presence.
Cardiac patch technology addressing structural heart defects; differentiated from synthetic alternatives.
No open positions listed yet. Check their careers page directly.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo